UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Infosys
INFY
|
+$792M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$300M |
| 3 |
Amazon
AMZN
|
+$281M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$260M |
| 5 |
NVIDIA
NVDA
|
+$258M |
Top Sells
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$329M |
| 2 |
Alibaba
BABA
|
+$321M |
| 3 |
Citigroup
C
|
+$294M |
| 4 |
Charter Communications
CHTR
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$216M |
Sector Composition
| 1 | Technology | 25.36% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.18% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
CyberArk
CYBR
$23.6B
| $15.1M | 0.01% |
116,608
+4,627
| +4% | +$598K |
|
|
MSP
902
DELISTED
Datto Holding Corp.
MSP
| $15M | 0.01% |
+654,610
| New | +$15M |
|
903
PTC Therapeutics
PTCT
$4.63B
| $15M | 0.01% |
316,202
-127,940
| -29% | -$6.06M |
|
904
Avnet
AVT
$4.5B
| $14.9M | 0.01% |
359,535
-30,645
| -8% | -$1.27M |
|
905
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| – | – |
0
| – | -$19.5M |
|
906
Jabil
JBL
$23.2B
| $14.9M | 0.01% |
284,948
-16,045
| -5% | -$837K |
|
|
SAGE
907
DELISTED
Sage Therapeutics
SAGE
| $14.8M | 0.01% |
197,634
-211,166
| -52% | -$15.8M |
|
908
Relay Therapeutics
RLAY
$700M
| $14.7M | 0.01% |
425,451
-58,944
| -12% | -$2.04M |
|
909
Bruker
BRKR
$4.63B
| $14.7M | 0.01% |
228,259
+5,627
| +3% | +$362K |
|
910
argenx
ARGX
$46.7B
| $14.7M | 0.01% |
53,265
-16,831
| -24% | -$4.64M |
|
911
Kennedy-Wilson Holdings
KW
$1.23B
| $14.6M | 0.01% |
720,567
+49,769
| +7% | +$1.01M |
|
912
WEX
WEX
$5.81B
| $14.5M | 0.01% |
69,305
-318
| -0.5% | -$66.5K |
|
913
Casey's General Stores
CASY
$20B
| $14.3M | 0.01% |
66,187
-1,030
| -2% | -$223K |
|
914
Sunstone Hotel Investors
SHO
$1.76B
| $14.3M | 0.01% |
1,145,528
-9,988
| -0.9% | -$124K |
|
915
Four Corners Property Trust
FCPT
$2.68B
| $14.2M | 0.01% |
519,655
+66,418
| +15% | +$1.82M |
|
916
Encompass Health
EHC
$12.6B
| $14.2M | 0.01% |
218,121
+17,844
| +9% | +$1.16M |
|
|
BZUN
917
Baozun
BZUN
$230M
| $14.1M | 0.01% |
369,793
+9,916
| +3% | +$378K |
|
918
National Health Investors
NHI
$3.71B
| $14.1M | 0.01% |
194,708
-64,262
| -25% | -$4.64M |
|
|
AMED
919
DELISTED
Amedisys
AMED
| $14M | 0.01% |
52,717
-659
| -1% | -$174K |
|
920
Penumbra
PEN
$10.6B
| $13.9M | 0.01% |
51,516
-6,142
| -11% | -$1.66M |
|
921
Five Below
FIVE
$8.05B
| $13.9M | 0.01% |
72,827
-9,760
| -12% | -$1.86M |
|
922
Darling Ingredients
DAR
$4.95B
| $13.9M | 0.01% |
188,836
-451
| -0.2% | -$33.2K |
|
923
Polaris
PII
$3.29B
| $13.9M | 0.01% |
104,054
-8,568
| -8% | -$1.14M |
|
924
XP
XP
$9.83B
| $13.9M | 0.01% |
368,720
+5,376
| +1% | +$203K |
|
925
ITT
ITT
$13.6B
| $13.9M | 0.01% |
152,536
-4,344
| -3% | -$395K |
|